|
US4602035A
(en)
*
|
1983-12-07 |
1986-07-22 |
Hoechst-Roussel Pharmaceuticals Inc. |
Antidepressant (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines
|
|
GB8419963D0
(en)
*
|
1984-08-06 |
1984-09-12 |
Lundbeck & Co As H |
Intermediate compound and method
|
|
GB8814057D0
(en)
*
|
1988-06-14 |
1988-07-20 |
Lundbeck & Co As H |
New enantiomers & their isolation
|
|
DK0759299T3
(da)
*
|
1995-08-16 |
2000-08-07 |
Lilly Co Eli |
Potensering af serotoninrespons
|
|
JP3526581B2
(ja)
*
|
1997-07-08 |
2004-05-17 |
ハー・ルンドベック・アクティーゼルスカブ |
シタロプラムの製造方法
|
|
UA62985C2
(en)
*
|
1997-11-10 |
2004-01-15 |
Lunnbeck As H |
A method for the preparation of citalopram
|
|
JP3813820B2
(ja)
*
|
1997-11-11 |
2006-08-23 |
ハー・ルンドベック・アクチエゼルスカベット |
シタロプラムの製造方法
|
|
HU228576B1
(en)
|
1998-10-20 |
2013-04-29 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
|
HRP20010418A2
(en)
|
1998-12-08 |
2002-06-30 |
Lundbeck & Co As H |
Benzofuran derivatives, their preparation and use
|
|
AR021509A1
(es)
*
|
1998-12-08 |
2002-07-24 |
Lundbeck & Co As H |
Derivados de benzofurano, su preparacion y uso
|
|
NZ512073A
(en)
|
1998-12-23 |
2003-10-31 |
H |
Method for the preparation of 5-cyanophthalide and citalopram
|
|
AR022329A1
(es)
|
1999-01-29 |
2002-09-04 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-cianoftalida
|
|
AU759716B2
(en)
*
|
1999-04-14 |
2003-04-17 |
H. Lundbeck A/S |
Method for the preparation of citalopram
|
|
ITMI991581A1
(it)
*
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
|
ITMI991579A1
(it)
*
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
|
ITMI991486A1
(it)
*
|
1999-07-06 |
2001-01-06 |
Vis Farmaceutici S P A |
Processo per la sintesi di citalopram
|
|
AR021155A1
(es)
*
|
1999-07-08 |
2002-06-12 |
Lundbeck & Co As H |
Tratamiento de desordenes neuroticos
|
|
TR200101874T1
(tr)
|
1999-10-25 |
2002-02-21 |
H. Lundbeck A/S |
Sitalopram hazırlanması için yöntem
|
|
TR200401456T1
(tr)
|
1999-10-25 |
2005-04-21 |
H. Lundbeck A/S |
Sitalopram hazırlanması için yöntem.
|
|
US6310222B1
(en)
*
|
1999-11-01 |
2001-10-30 |
Sumika Fine Chemicals Co., Ltd. |
Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
|
|
AR026063A1
(es)
|
1999-11-01 |
2002-12-26 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-carboxiftalida.
|
|
SK9282002A3
(en)
|
1999-12-28 |
2002-11-06 |
Lundbeck & Co As H |
Method for the preparation of citalopram, pharmaceutical composition comprising same and intermediates
|
|
WO2001049672A1
(en)
*
|
1999-12-30 |
2001-07-12 |
H. Lundbeck A/S |
Method for the preparation of citalopram
|
|
ATE252570T1
(de)
*
|
2000-01-14 |
2003-11-15 |
Lundbeck & Co As H |
Verfahren zur herstellung von 5-cyanophthalid
|
|
US6433196B1
(en)
*
|
2000-02-17 |
2002-08-13 |
Sumika Fine Chemicals Co., Ltd. |
Production method of citalopram, intermediate therefor and production method of the intermediate
|
|
IES20010143A2
(en)
*
|
2000-02-24 |
2001-07-25 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
|
NL1017415C1
(nl)
*
|
2000-02-24 |
2001-05-18 |
Lundbeck & Co As H |
Werkwijze voor de bereiding van Citalopram.
|
|
NL1017417C1
(nl)
*
|
2000-03-03 |
2001-03-16 |
Lundbeck & Co As H |
Werkwijze voor de bereiding van Citalopram.
|
|
GB0005477D0
(en)
|
2000-03-07 |
2000-04-26 |
Resolution Chemicals Limited |
Process for the preparation of citalopram
|
|
CN1427835A
(zh)
*
|
2000-03-13 |
2003-07-02 |
H·隆德贝克有限公司 |
5－取代的1－(4－氟苯基)－1,3－二氢异苯并呋喃的分步烷基化
|
|
NL1017500C1
(nl)
|
2000-03-13 |
2001-04-26 |
Lundbeck & Co As H |
Werkwijze voor de bereiding van Citalopram.
|
|
SK14602002A3
(sk)
|
2000-03-13 |
2003-02-04 |
H. Lundbeck A/S |
Spôsob výroby citalopramu a medziprodukty
|
|
GB2357762B
(en)
|
2000-03-13 |
2002-01-30 |
Lundbeck & Co As H |
Crystalline base of citalopram
|
|
PL360107A1
(en)
|
2000-03-14 |
2004-09-06 |
H.Lundbeck A/S |
Method for the preparation of citalopram
|
|
IL151487A0
(en)
*
|
2000-03-16 |
2003-04-10 |
Lundbeck & Co As H |
Method for the preparation of 5-cyano-1-(4-flourophenyl)-1,3-dihydroisobenzofurans
|
|
CA2406383A1
(en)
*
|
2000-04-13 |
2001-10-25 |
Mayo Foundation For Medical Education And Research |
A.beta.42 lowering agents
|
|
US6977306B2
(en)
*
|
2000-05-02 |
2005-12-20 |
Sumitomo Chemical Company, Limited |
Citalopram hydrobromide crystal and method for crystallization thereof
|
|
KR100821912B1
(ko)
*
|
2000-05-12 |
2008-04-16 |
하. 룬트벡 아크티에 셀스카브 |
시탈로프람의 제조 방법
|
|
AR032455A1
(es)
|
2000-05-12 |
2003-11-12 |
Lundbeck & Co As H |
Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
|
|
EA200200332A1
(ru)
*
|
2000-07-06 |
2002-06-27 |
Х.Лундбекк А/С |
Способ получения циталопрама
|
|
WO2002008216A1
(en)
*
|
2000-07-21 |
2002-01-31 |
H. Lundbeck A/S |
Novel compounds and their use as glycine transport inhibitors
|
|
IS6021A
(is)
*
|
2000-08-10 |
2001-10-20 |
H. Lundbeck A/S |
Lyfjasamsetningar sem innihalda sítalópram
|
|
IL144817A0
(en)
*
|
2000-08-18 |
2002-06-30 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
|
US20030232881A1
(en)
*
|
2000-10-27 |
2003-12-18 |
H. Lundbeck A/S |
Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
|
|
US20030109577A1
(en)
*
|
2000-10-27 |
2003-06-12 |
Ken Liljegren |
Pharmaceutical composition containing citalopram
|
|
IT1319686B1
(it)
*
|
2000-12-12 |
2003-10-23 |
C D Farmasint S R L |
Procedimento di preparazione di citalopram.
|
|
DE60105926T2
(de)
*
|
2000-12-22 |
2005-11-24 |
H. Lundbeck A/S, Valby |
Verfahren zur vorbereitung von reinem citalopram
|
|
BR0106271A
(pt)
*
|
2000-12-28 |
2002-05-21 |
Lundbeck & Co As H |
Processo para preparação de citalopram puro
|
|
DE10112828C1
(de)
*
|
2000-12-28 |
2002-11-21 |
Lundbeck & Co As H |
Verfahren zur Herstellung von Citalopram
|
|
DE10164725B4
(de)
*
|
2000-12-28 |
2004-08-26 |
H. Lundbeck A/S |
Verfahren zur Herstellung von gereinigtem Citalopram
|
|
AU2001100195B4
(en)
*
|
2001-01-05 |
2001-12-20 |
H Lundbeck As |
Pharmaceutical composition containing citalopram.
|
|
CA2435925A1
(en)
|
2001-01-30 |
2002-08-08 |
Orion Corporation Fermion |
Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
|
|
JP2004529883A
(ja)
*
|
2001-02-22 |
2004-09-30 |
ナトコ ファーマ リミテッド |
シタロプラムの調製方法
|
|
GB0105627D0
(en)
|
2001-03-07 |
2001-04-25 |
Cipla Ltd |
Preparation of phthalanes
|
|
EP1370545A4
(en)
*
|
2001-03-09 |
2005-03-16 |
Ranbaxy Lab Ltd |
PROCESS FOR THE PREPARATION OF CITALOPRAM
|
|
CZ20033267A3
(en)
*
|
2001-05-01 |
2004-06-16 |
H. Lundbeck A/S |
The use of enantiomeric pure escitalopram
|
|
BG65271B1
(bg)
*
|
2001-06-18 |
2007-11-30 |
H. Lundbeck A/S |
Метод за получаване на циталопрам
|
|
AR034759A1
(es)
*
|
2001-07-13 |
2004-03-17 |
Lundbeck & Co As H |
Metodo para la preparacion de escitalopram
|
|
IN192057B
(enExample)
*
|
2001-07-19 |
2004-02-14 |
Ranbaxy Lab Ltd |
|
|
MEP2108A
(xx)
*
|
2001-07-31 |
2010-02-10 |
Lundbeck & Co As H |
Kristalni sastav koji sadrži escitalopram
|
|
EP1288211A1
(en)
*
|
2001-08-28 |
2003-03-05 |
Sekhsaria Chemicals Ltd. |
Improved process for the manufacture of citalopram hydrobromide from 5-bromophthalide
|
|
US6967259B2
(en)
*
|
2001-09-24 |
2005-11-22 |
Pharmachem Technologies Limited |
Process for the preparation of Citalopram intermediate
|
|
JP4494015B2
(ja)
*
|
2001-10-12 |
2010-06-30 |
アゼヴァン ファーマスーティカルズ，インコーポレイテッド |
β−ラクタミル・バソプレッシンＶ１ａ拮抗剤
|
|
IN192863B
(enExample)
*
|
2001-11-13 |
2004-05-22 |
Ranbaxy Lab Ltd |
|
|
IS7239A
(is)
*
|
2001-12-14 |
2004-04-29 |
H. Lundbeck A/S |
Aðferð til framleiðslu á essítalóprami
|
|
WO2003057132A2
(en)
*
|
2002-01-07 |
2003-07-17 |
Sun Pharmaceutical Industries Limited |
Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
|
|
GB2385848A
(en)
*
|
2002-02-27 |
2003-09-03 |
Cipla Ltd |
Citalopram salts
|
|
GB0204607D0
(en)
*
|
2002-02-27 |
2002-04-10 |
Matrix Lab Ltd |
Process
|
|
GB2387596B
(en)
*
|
2002-02-27 |
2004-02-11 |
Matrix Lab Ltd |
Process
|
|
EP1346989A1
(en)
*
|
2002-03-21 |
2003-09-24 |
Jubilant Organosys Limited |
Improved process for the preparation of citalopram and its hydrobromide
|
|
WO2003080558A1
(en)
*
|
2002-03-27 |
2003-10-02 |
Bando Chemical Industries, Ltd. |
Novel 1,3,5-tris(arylamino)benzene
|
|
CA2381341A1
(en)
*
|
2002-04-09 |
2003-10-09 |
Torcan Chemical Ltd. |
Process and intermediates for preparing escitalopram
|
|
FI20021421A0
(fi)
*
|
2002-07-30 |
2002-07-30 |
Orion Corp Fermion |
Valmistusmenetelmä
|
|
PE20040991A1
(es)
*
|
2002-08-12 |
2004-12-27 |
Lundbeck & Co As H |
Separacion de intermediarios para la preparacion de escitalopram
|
|
AU2002330730A1
(en)
*
|
2002-08-14 |
2004-03-03 |
Natco Pharma Limited |
Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts
|
|
GB2385051B
(en)
*
|
2002-08-29 |
2003-12-24 |
Max India Ltd |
Improved process for the preparation of 5-substituted-1 (4-fluorophenyl)-1,3-dihydro isobenzofurans
|
|
US6812355B2
(en)
|
2002-10-22 |
2004-11-02 |
Sekhsaria Chemicals Limited |
Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
|
|
UA80170C2
(en)
*
|
2002-12-23 |
2007-08-27 |
Lundbeck & Co As H |
Escitalopram hydrobromide
|
|
US20050137255A1
(en)
*
|
2002-12-23 |
2005-06-23 |
H. Lundbeck A/S |
Crystalline escitalopram hydrobromide and methods for preparing the same
|
|
AU2003242990A1
(en)
*
|
2003-01-17 |
2004-08-13 |
Pulla Reddy Muddasani |
Processes for the preparation of escitalopram and its precursor
|
|
EP1603548A4
(en)
*
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
|
|
ITMI20030479A1
(it)
*
|
2003-03-13 |
2004-09-14 |
Adorkem Technology S P A |
Procedimento per la preparazione di un ciano-isobenzofurano.
|
|
US7019153B2
(en)
*
|
2003-06-10 |
2006-03-28 |
Sun Pharmaceutical Industries Limited |
Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
|
|
US20050042284A1
(en)
*
|
2003-07-11 |
2005-02-24 |
Myriad Genetics, Incorporated |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
|
|
GB0317475D0
(en)
*
|
2003-07-25 |
2003-08-27 |
Meditab Specialities Pvt Ltd |
Product
|
|
ITFI20030202A1
(it)
*
|
2003-07-28 |
2005-01-29 |
Synteco Spa |
Processo per la preparazione di derivati del
|
|
SG146683A1
(en)
*
|
2003-09-17 |
2008-10-30 |
Janssen Pharmaceutica Nv |
Fused heterocyclic compounds as serotonin receptor modulators
|
|
DK1506963T3
(da)
*
|
2003-10-28 |
2005-08-01 |
Adorkem Technology Spa |
Fremgangsmåde til fremstilling af citalopram
|
|
AU2003278409A1
(en)
*
|
2003-10-28 |
2005-05-19 |
Krishnaji Upadhye Bhargav |
Improved process for the manufacture of citalopram hydrobromide
|
|
US20050143350A1
(en)
*
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
WO2005053796A1
(en)
*
|
2003-12-02 |
2005-06-16 |
B & B Beheer Nv |
Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
|
|
CA2548917C
(en)
|
2003-12-11 |
2014-09-23 |
Sepracor Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
|
CN100569765C
(zh)
*
|
2003-12-19 |
2009-12-16 |
杭州民生药业集团有限公司 |
西酞普兰中间体晶体碱
|
|
TWI339651B
(en)
*
|
2004-02-12 |
2011-04-01 |
Lundbeck & Co As H |
Method for the separation of intermediates which may be used for the preparation of escitalopram
|
|
WO2005077927A1
(en)
*
|
2004-02-16 |
2005-08-25 |
Jubilant Organosys Limited |
One pot synthesis of citalopram from 5-cyanophthalide
|
|
US20050196453A1
(en)
*
|
2004-03-05 |
2005-09-08 |
H. Lundbeck A/S |
Crystalline composition containing escitalopram
|
|
ITMI20040717A1
(it)
*
|
2004-04-09 |
2004-07-09 |
Adorkem Technology Spa |
Procedimento chemo-enzimatico per la preparazione dell'escitalopram
|
|
WO2006001877A2
(en)
*
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
EP1737473A4
(en)
*
|
2004-04-19 |
2009-08-26 |
Noven Therapeutics Llc |
COMBINATIONS OF LITHIUM AND USES THEREOF
|
|
WO2005108683A1
(en)
*
|
2004-04-29 |
2005-11-17 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
BRPI0514303A
(pt)
*
|
2004-08-11 |
2008-06-10 |
Myriad Genetics Inc |
composição farmacêutica e método para tratar distúrbios neurodegenerativos
|
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
EP2141156A1
(en)
|
2004-08-23 |
2010-01-06 |
Sun Pharma Global FZE |
Process for Preparation of Citalopram and Enantiomers
|
|
US7989645B2
(en)
*
|
2004-08-23 |
2011-08-02 |
Sun Pharma Global Fze |
Process for preparation of citalopram and enantiomers
|
|
WO2006102308A2
(en)
|
2005-03-22 |
2006-09-28 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl vasopressin v1b antagonists
|
|
WO2006103550A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Ranbaxy Laboratories Limited |
Processes for the preparation of citalopram and its intermediate 5-aminophthalide
|
|
AU2006239922A1
(en)
*
|
2005-04-22 |
2006-11-02 |
Wyeth |
Benzofuranyl alkanamine derivatives and uses thereof as 5-HT2c agonists
|
|
JP2008538581A
(ja)
*
|
2005-04-22 |
2008-10-30 |
ワイス |
｛［（２ｒ）−７−（２，６−ジクロロフェニル）−５−フルオロ−２，３−ジヒドロ−１−ベンゾフラン−２−イル］メチル｝アミン塩酸塩の結晶形態
|
|
BRPI0608475A2
(pt)
|
2005-04-22 |
2010-01-05 |
Wyeth Corp |
derivados de diidrobenzofurano e usos dos mesmos
|
|
TW200719886A
(en)
*
|
2005-04-22 |
2007-06-01 |
Wyeth Corp |
Dihydrobenzofuran derivatives and uses thereof
|
|
US7834201B2
(en)
|
2005-06-22 |
2010-11-16 |
H. Lundbeck A/S |
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
|
|
TWI347942B
(en)
|
2005-06-22 |
2011-09-01 |
Lundbeck & Co As H |
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
|
|
SG163588A1
(en)
|
2005-07-08 |
2010-08-30 |
Braincells Inc |
Methods for identifying agents and conditions that modulate neurogenesis
|
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
|
JP5328349B2
(ja)
*
|
2005-07-19 |
2013-10-30 |
アゼヴァン ファーマスーティカルズ，インコーポレイテッド |
ベータ−ラクタミルフェニルアラニン、システイン、およびセリン・バソプレッシン拮抗剤
|
|
EP1909777A2
(en)
*
|
2005-07-22 |
2008-04-16 |
Myriad Genetics, Inc. |
High drug load formulations and dosage forms
|
|
US7598255B2
(en)
*
|
2005-08-04 |
2009-10-06 |
Janssen Pharmaceutica Nv |
Pyrimidine compounds as serotonin receptor modulators
|
|
CA2625153A1
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
CA2625210A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
CN101309924A
(zh)
*
|
2005-11-14 |
2008-11-19 |
H.隆德贝克有限公司 |
依地普仑的制备方法
|
|
GB0601286D0
(en)
|
2006-01-23 |
2006-03-01 |
Sandoz Ag |
Asymmetric synthesis
|
|
FR2912057B1
(fr)
*
|
2007-02-07 |
2009-04-17 |
Sanofi Aventis Sa |
Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
|
|
WO2007104035A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
TW200806300A
(en)
*
|
2006-03-24 |
2008-02-01 |
Wyeth Corp |
New therapeutic combinations for the treatment of depression
|
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
EP2382975A3
(en)
|
2006-05-09 |
2012-02-29 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
MX2008014320A
(es)
|
2006-05-09 |
2009-03-25 |
Braincells Inc |
Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
|
|
US7858611B2
(en)
*
|
2006-05-09 |
2010-12-28 |
Braincells Inc. |
Neurogenesis by modulating angiotensin
|
|
EP2046119A2
(en)
*
|
2006-07-07 |
2009-04-15 |
Myriad Genetics, Inc. |
Treatment of psychiatric disorders
|
|
WO2008059514A2
(en)
*
|
2006-07-31 |
2008-05-22 |
Cadila Healthcare Limited |
Process for preparing escitalopram
|
|
TW200817003A
(en)
*
|
2006-07-31 |
2008-04-16 |
Sanofi Aventis |
Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
|
|
JP2010502722A
(ja)
*
|
2006-09-08 |
2010-01-28 |
ブレインセルス，インコーポレイティド |
４−アシルアミノピリジン誘導体を含む組み合わせ
|
|
US20100016274A1
(en)
*
|
2006-09-14 |
2010-01-21 |
Koppel Gary A |
Beta-lactam cannabinoid receptor modulators
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
US20080103165A1
(en)
*
|
2006-09-19 |
2008-05-01 |
Braincells, Inc. |
Ppar mediated modulation of neurogenesis
|
|
JP4927497B2
(ja)
*
|
2006-10-25 |
2012-05-09 |
株式会社シスコ |
無湿乾燥用ホッパー装置
|
|
CN100457747C
(zh)
*
|
2006-11-21 |
2009-02-04 |
浙江大学 |
抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺
|
|
US20080167363A1
(en)
*
|
2006-12-28 |
2008-07-10 |
Braincells, Inc |
Modulation of Neurogenesis By Melatoninergic Agents
|
|
AU2008204800A1
(en)
*
|
2007-01-11 |
2008-07-17 |
Braincells, Inc. |
Modulation of neurogenesis with use of modafinil
|
|
US7566793B2
(en)
*
|
2007-04-23 |
2009-07-28 |
Synthon Bv |
Process for resolving citalopram
|
|
NZ580738A
(en)
*
|
2007-05-18 |
2012-02-24 |
Cipla Ltd |
Process for the preparation of escitalopram
|
|
US20080312318A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Protia, Llc |
Deuterium-enriched escitalopram
|
|
EP2017271A1
(en)
|
2007-07-06 |
2009-01-21 |
Aurobindo Pharma Limited |
Process for the preparation of escitalopram
|
|
US8022232B2
(en)
*
|
2007-09-11 |
2011-09-20 |
H. Lundbeck A/S |
Method for manufacture of escitalopram
|
|
KR101103118B1
(ko)
*
|
2007-11-02 |
2012-01-04 |
동아제약주식회사 |
신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물
|
|
EP2288345B1
(en)
|
2008-04-18 |
2015-06-10 |
University College Dublin National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
EP2116231A1
(en)
|
2008-05-07 |
2009-11-11 |
Hexal Ag |
Granulate comprising escitalopram oxalate
|
|
US20100087664A1
(en)
*
|
2008-10-07 |
2010-04-08 |
Ravindra Vedantham |
Preparation of citalopram and salts thereof
|
|
GR20080100696A
(el)
|
2008-10-23 |
2010-05-13 |
Genepharm �.�. |
Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
HUE043962T2
(hu)
|
2009-10-23 |
2019-09-30 |
Janssen Pharmaceutica Nv |
Diszubsztituált oktahidro-pirrolo[3,4-C]pirrolok mint orexin receptor modulátorok
|
|
JP2013535425A
(ja)
|
2010-07-01 |
2013-09-12 |
アゼヴァン ファーマシューティカルズ，インコーポレイテッド |
心的外傷後ストレス障害を治療する方法
|
|
WO2013081567A1
(en)
|
2011-12-02 |
2013-06-06 |
Mahmut Bilgic |
Effervescent antipsychotic formulations
|
|
WO2013100870A1
(en)
|
2011-12-02 |
2013-07-04 |
Mahmut Bilgic |
New antipsychotic compositions
|
|
WO2013110313A1
(en)
*
|
2012-01-23 |
2013-08-01 |
H. Lundbeck A/S |
Selective allosteric modulators of the serotonin transporter
|
|
JP7255967B2
(ja)
|
2014-03-28 |
2023-04-11 |
アゼヴァン ファーマスーティカルズ，インコーポレイテッド |
神経変性疾患を治療するための組成物および方法
|
|
CA3016706A1
(en)
|
2016-03-10 |
2017-09-14 |
Janssen Pharmaceutica Nv |
Methods of treating depression using orexin-2 receptor antagonists
|
|
CN111295373B
(zh)
|
2017-09-15 |
2024-12-10 |
阿泽凡药物公司 |
用于治疗脑损伤的组合物和方法
|
|
KR20220049526A
(ko)
|
2019-07-19 |
2022-04-21 |
바이오엑셀 테라퓨틱스 인코포레이티드 |
비-진정성 덱스메데토미딘 치료 양생법
|
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|